Whereas Cten appears to be down-regulated in prostate and kidney cancers [8,9], it has been found to be up-regulated and proposed to function as an oncogene in thymomas, lung, gastric, colorectal, breast, and pancreatic cancers [10-16]. The gene discussed is TNS4; the disease is familial pancreatic carcinoma.